Management of haemophilia B patients with inhibitors and anaphylaxis

Haemophilia

Volumn 4, Issue 4, 1998, Pages 574-576

  Warrier, I ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Anaphylaxis; FIX inhibitor; Hemophilia B; rFVIIa

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 8 INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ANAPHYLAXIS; BLEEDING; CLINICAL ARTICLE; CONFERENCE PAPER; HEMOPHILIA B; HUMAN; IMMUNOLOGICAL TOLERANCE; MALE; NEPHROTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0031830491     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.440574.x     Document Type: Conference Paper

References (8)

1. Warrier I, Ewenstein BM, Koerper MA, Shapiro A, et al. Factor IX inhibitors and anaphylaxis in haemophilia B. J Pediatr Hematol Oncol 1997; 19: 23-7.
2. Warrier I, Ewenstein BM, Koerper MA, et al. FIX inhibitor and anaphylaxis in haemophilia B correspondence. Haemophilia 1996; 2: 259-61.
3. Warrier I, Lusher JM. Recombinant (r) factor Vila (Novo-Seven) is the most appropriate treatment for children with hemophilia B complicated by inhibitor antibodies and anaphylaxis to FIX containing products. Blood 1996; 88 (Suppl 1): 442a.
4. Bergman F, Vester U, Rose M, Hoyer PF, Bohn U, Barthels M. Behandlungsaltervativen bei Hemmorkörperhämophilie B: Erfahrungen mit dem Einsatz von rekombinatem Faktor VIIa (rFVIIa). In: Scharrer I, Schramm W, eds. Hämophilie-Symposium. Hamburg, Berlin, Heidelberg: Springer Verlag 1994; 126-9.
5. Collins PW, Fields P, Goldman E, Lee CA and Pasi KJ. The use of rFVIIa to treat a factor IX inhibitor following anaphylaxis with factor IX concentrate. Blood Coagulation and Fibrinolysis 1995; 6: 177.
6. Ewenstein BM, Takemoto C, Warrier I, Lusher J, Saidi P, Eisele J, et al. Nephrotic syndrome as a complication of immune tolerance in hemophilia B. Blood 1997; 89: 115-6.
7. Lenk H, Bierback U, Schille R. Inhibitor to FIX in haemophilia B and nephrotic syndrome in the course of immune tolerance treatment. Haemophilia 1996; 2 (Suppl 1): 104.
8. Pollmann H. A haemophilia B patient with complete factor IX gene deletion and a high titer antibody against FIX. Haemophilia 1996; 2 (Suppl 1): 72.